Skip to main content
. 2019 Apr 30;7(4):2325967119839998. doi: 10.1177/2325967119839998

TABLE 3.

Outcomes According to Presence of Enthesophytesa

Total Enthesophytes No Enthesophytes P Value
Complications, n (%) 15 (21.7) 8 (44.4) 7 (13.7) .027
 Persistent pain/numbness 8 4 4 .196
 Tendon calcification or thickening 4 3 1 .130
 Triceps adhesion 1 0 1 .322
 Olecranon cyst 1 1 0 .331
 Dehiscence 1 0 1 .322
SANE score 89.9 ± 14.6 80.3 ± 24.8 92.6 ± 8.8 .103
VAS score 0.9 ± 1.7 2.1 ± 2.9 0.6 ± 0.9 .062
KJOC score 84.5 ± 20.0 85.6 ± 17.5 84.2 ± 20.9 .875
VR-12 score 0.8 ± 0.1 0.8 ± 0.2 0.8 ± 0.1 .590
MEPS score 90.7 ± 29.7 84.4 ± 17.0 93.0 ± 11.4 .217
QuickDASH score 9.7 ± 16.3 16.1 ± 21.8 7.1 ± 12.7 .202

aData are reported as mean ± SD, unless otherwise specified. Bolded P value indicates a statistically significant difference between patients with enthesophytes versus no enthesophytes (P < .05). KJOC, Kerlan-Jobe Orthopaedic Clinic; MEPS, Mayo Elbow Performance Score; QuickDASH, Quick Disabilities of the Arm, Shoulder and Hand; SANE, Single Assessment Numeric Evaluation; VAS, visual analog scale; VR-12, Veterans RAND 12-Item Health Survey.